Resistance to macrolides and lincosamides is increasingly reported in clinical isolates of
gram-positive bacteria. The multiplicity of mechanisms of resistance, which include …

Streptococcus pneumoniae is a common commensal and an opportunistic pathogen.
Suspected pneumococcal upper respiratory infections and pneumonia are often treated with …

Clin Microbiol Infect 2011; 17 (Suppl. 6): E1–E59 Abstract This document is an update of
Guidelines published in 2005 and now includes scientific publications through to May 2010 …

Resistance to erythromycin in Streptococcus pneumoniae was first detected in 1967 in the
United States and subsequently worldwide (11, 20). The corresponding mechanism was …

Reduction of drug-resistant Streptococcus pneumoniae (DRSP) by pneumococcal conjugate
vaccines (PCVs) has recently become a reality. We now know that (1) most clinically …

Streptococcus pyogenes (29) and Streptococcus pneumoniae (63) clinical isolates. This
trend was partly due to a further spread of the conventional methylase-mediated target site …

Susceptibility testing results for Streptococcus pneumoniae isolates (n= 2,279) from eight
European countries, examined in the PneumoWorld Study from 2001 to 2003, are …

The acquisition of vancomycin resistance by Gram-positive bacteria and carbapenem
resistance by Gram-negative bacteria has rendered some hospital-acquired pathogens …

Purpose. Streptococcus pneumoniae is a commensal bacterium that normally colonizes the
human nasopharyngeal cavity. Once disseminated, it can cause several diseases, ranging …

In this study, the distribution of macrolide resistance mechanisms was determined for
isolates of Streptococcus pneumoniae and Streptococcus pyogenes obtained from the …